FDA perspective on the need for revised performance goals for evaluating stenting of femoropopliteal arteries
Catheter Cardiovasc Interv
.
2014 May 1;83(6):984-6.
doi: 10.1002/ccd.25221.
Epub 2013 Nov 8.
Authors
Lindsay K Pack
1
,
Donna C Buckley
,
Jennifer L Goode
,
Steven S Brooks
,
Lisa M Lim
Affiliation
1
Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation, Silver Spring, Maryland.
PMID:
24285586
DOI:
10.1002/ccd.25221
No abstract available
Publication types
Editorial
Comment
MeSH terms
Alloys*
Endovascular Procedures / instrumentation*
Femoral Artery*
Humans
Peripheral Arterial Disease / therapy*
Popliteal Artery*
Stents*
Substances
Alloys
nitinol